Recurrence is commonly associated with low-grade upper tract urothelial carcinoma and may be predicted by smoking status and tumor size.
“The results showed the contemporary Aquablation procedural safety in Japanese men is exceptional in a broad range of prostate sizes along with significant symptom reduction,”…
“This was a very special moment, delivering the news to this patient that his cancer is now undetectable following the treatment with 2 doses of…
A late phase 3 trial evaluating the agent is underway at several clinics in Europe.
“This clinical study has the potential to demonstrate the value of Chimeric Antigen Receptor (CAR) T cell therapy in solid cancers such as kidney cancer…
“It’s a system that is still not being used to its maximum capability, which is exciting. That means we can continue evolving,” says Jaschar Shakuri-Rad,…
The first patient was treated with TLX250-CDx at the Olivia Newton-John Cancer Wellness Centre at Austin Health in Melbourne, Australia,
“It is important as a field that we recognize the potential emotional impact of surgical adverse events,” writes Amy N. Luckenbaugh, MD.
Following the positive recommendation, the European Commission will now review the application for vibegron for potential approval in the OAB setting in all EU member…
“There are opportunities for doctors to become more productive, to see more patients, and to avoid the erosion of their incomes,” writes Neil Baum, MD.
“We are hopeful that this therapy will help patients with prostate cancer and that this study will be just the first step towards the effective…
